Actinium Pharmaceuticals, Inc. (ATNM) Financials
ATNM Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 88.9 million | 45.4 million |
2023-06-30 | 99.1 million | 46.0 million |
2023-03-31 | 102.0 million | 44.8 million |
2022-12-31 | 114.2 million | 47.7 million |
ATNM Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -11.2 million | 921000 |
2023-06-30 | -13.7 million | 1.0 million |
2023-03-31 | -15.2 million | 993000 |
2022-12-31 | -7.8 million | 979000 |
ATNM Net Income
No data available :(
ATNM Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 83.0 million | - | 2.2 million |
2023-06-30 | 91.3 million | - | 2.3 million |
2023-03-31 | 94.5 million | - | 2.5 million |
2022-12-31 | 108.9 million | - | 2.6 million |
ATNM Shares Outstanding
ATNM Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 30000 | 11.6 million | 2.7 million | - |
2023-06-30 | 47000 | 11.1 million | 4.6 million | - |
2023-03-31 | 76000 | 7.8 million | 3.7 million | - |
2022-12-31 | 16000 | 7.3 million | 4.0 million | - |
ATNM Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 200000 |
2023-06-30 | - | 209000 |
2023-03-31 | - | 182000 |
2022-12-31 | 114000 | 161000 |
ATNM
Price: $8.96
52 week price:
Earnings Per Share: -1.93 USD
P/E Ratio: -2.83
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Volume: 219900
Market Capitalization: 246.7 million